AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2015
Apr 2, 2015
29777_dirs_2015-04-02_132f3a89-ece8-4128-8de2-5d2dbdcf6916.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Mylan N.V. (MYL)
CIK: 0001623613
Period of Report: 2015-03-31
Reporting Person: ABBOTT LABORATORIES (10% Owner)
Reporting Person: Laboratoires Fournier S.A.S. (10% Owner)
Reporting Person: Abbott Established Products Holdings Gibraltar Ltd (10% Owner)
Reporting Person: Abbott Investments Luxembourg S.A R.L. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-31 | Ordinary Shares, nominal value euro 0.01 per share | J | 35000000 | $56.8912 | Disposed | 75000000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | Call Option (Obligation to Sell) | $56.8912 | J | 1 | Disposed | 2015-04-30 | Ordinary Shares (5250000) | Indirect |
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25